HamzaHashmiMD

PubMed

• A comparative review of Aphexda and Mozobil for mobilization prior to stem cell collection.
  Lauren Dietz, Jessica Marini, Mary McGann, Hamza Hashmi> ;Journal of Oncology Pharmacy Practice. 2024 Apr 17
• How to manage prolonged immune effector cell-associated hematotoxicity (ICAHT) related to BCMA-directed myeloma therapy.
  James A Davis, Mary McGann, Jessica Marini, Hamza Hashmi> ;Expert Review of Anticancer Therapy. 2024 Apr 21
• ASTCT Committee on Practice Guidelines Survey on Evaluation and Management of Relapsed/Refractory Multiple Myeloma after Failure of Chimeric Antigen Receptor T Cell Th...
  Ambuj Kumar, Yoshihiro Inamoto, Mehdi Hamadani, Hamza Hashmi, Mohamed A Kharfan-Dabaja, Pashna N Munshi, Zachariah M DeFilipp, Bhagirathbhai Dholaria, Tania Jain, Migu...> ;Transplantation and Cellular Therapy. 2024 Apr 12
• 1 citations
  Safety and efficacy of eltrombopag in patients with post-CAR T cytopenias.
  William Wesson, Nausheen Ahmed, Aliya Rashid, Carine Tabak, Emerson Logan, Jose Marchena-Burgos, Maggie Nelson, James A Davis, Mary McGann, Leyla Shune, Marc Hoffmann,...> ;European Journal of Haematology. 2024 Apr 1
• Efficacy and safety of daratumumab, pomalidomide, and dexamethasone versus daratumumab, carfilzomib, and dexamethasone in daratumumab-naïve relapsed multiple myeloma.
  Danai Dima, Razan Mansour, James A Davis, Megan Minchak, Utkarsh Goel, Rawan Atallah, Emerson Logan, Carine Tabak, Aliya Rashid, Nausheen Ahmed, Al-Ola Abdallah, Hamza...> ;European Journal of Haematology. 2024 Jun 1
• Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Mu...
  Gagelmann, N., Dima, D., Merz, M., Hashmi, H., Ahmed, N., Tovar, N., Oliver-Caldés, A., Stölzel, F., Rathje, K., Fischer, L., Born, P., Schäfer, L., Albici, A., Schub,...> ;Journal of Clinical Oncology. 2024 Feb 15
• Efficacy and safety of idecabtagene vicleucel in patients with relapsed-refractory multiple myeloma not meeting the KarMMa-1 trial eligibility criteria: A real-world m...
  Raza, S., Danai Dima, Aliya Rashid, James A Davis, Leyla Shune, Al-Ola Abdallah, Hong Li, Shaun DeJarnette, Jack Khouri, Louis Williams, Hamza Hashmi, Shahzad Raza, Jo...> ;British Journal of Haematology. 2024 Apr 1
• Impact of age, obesity, and renal impairment on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myeloma.
  Kelly J Gaffney, Jonathan K Bakos, Arash Velayati, James A Davis, Aswani Thurlapati, Erin Weeda, Andy Maldonado, Katelynn Granger, Coleen Butcher, Taylor Herrington, D...> ;Journal of Oncology Pharmacy Practice. 2024 Jan 2
• Impact of Cytogenetic Abnormalities, Induction and Maintenance Regimens on Outcomes After High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients W...
  Aswani Thurlapati, William Wesson, James A Davis, Kelly J Gaffney, Erin Weeda, Arash Velayati, Jonathan K Bakos, Katelynn Granger, Deidra Smith, Andy P Maldonado, Tayl...> ;Journal of Hematology. 2023 Dec 1
• Chimeric Antigen Receptor T-Cell Therapy in the Outpatient Setting: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.
  Olalekan O Oluwole, Bhagirathbhai Dholaria, Tristan E Knight, Tania Jain, Frederick L Locke, Linda Ramsdell, Sarah Nikiforow, Hamza Hashmi, Kathy Mooney, Shakthi T Bha...> ;Transplantation and Cellular Therapy. 2024 Feb 1
• Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study.
  Narendranath Epperla, Lei Feng, Nirav N Shah, Lindsey Fitzgerald, Harsh Shah, Deborah M Stephens, Catherine J Lee, Thomas Ollila, Geoffrey Shouse, Alexey V Danilov, Ke...> ;Journal of Hematology & Oncology. 2023 Nov 9
• Impact of race and ethnicity on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myeloma.
  James A Davis, Erin Weeda, Kelly J Gaffney, Deidra Smith, Andy Maldonado, Katelynn Granger, Kristy E Martin, Yolanda M Williams, Taylor Herrington, Arash Velayati, Jon...> ;Annals of Hematology. 2024 Jan 1
• Efficacy and Safety of Daratumumab, Pomalidomide, and Dexamethasone (DPd) Compared to Daratumumab, Bortezomib, and Dexamethasone (DVd) in Daratumumab-Naïve Relapsed Mu...
  Aimaz Afrough, Shebli Atrash, Barry Paul, Evguenia Ouchveridze, Nausheen Ahmed, Zahra Mahmoudjafari, Anam Bashir, Omar Alkharabsheh, Hamza Hashmi, Al-Ola Abdallah> ;Cancers. 2023 Oct 9
• 4 citations
  Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma with renal impairment.
  Surbhi Sidana, Lauren C Peres, Hamza Hashmi, Hitomi Hosoya, Christopher Ferreri, Jack Khouri, Danai Dima, Shebli Atrash, Peter Voorhees, Gary Simmons, Douglas W Sborov...> ;Haematologica. 2024 Mar 1
• 15 citations
  Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy.
  Castaneda Puglianini, O., Christopher J Ferreri, Michelle A T Hildebrandt, Hamza Hashmi, Leyla O Shune, Joseph P McGuirk, Douglas W Sborov, Charlotte B Wagner, M Hakan...> ;Blood Cancer Journal. 2023 Aug 9
• 1 citations
  Role of tixagevimab-cilgavimab in preventing SARS-CoV-2 in hematopoietic stem cell transplant and chimeric antigen receptor T-cell therapy recipients.
  Mary McGann, James A Davis, Katelynn Granger, Kiera Roubal, Deidra Smith, Kelly J Gaffney, Alyssa Cendagorta, Amanda Herbst, Lindsey Hendrickson, Brian T Hess, Hamza H...> ;Journal of Medical Virology. 2023 Aug 1
• 'A stitch in time saves nine': early stem cell transplant continues to improve outcomes in patients with newly diagnosed multiple myeloma.
  Hamza Hashmi, James A Davis, Al-Ola Abdallah> ;Expert Review of Hematology. 2023 Jun 23
• 2 citations
  Early cytopenias and infections following chimeric antigen receptor T-Cell therapy for hematologic malignancies.
  Mary McGann, Arash Velayati, Kiera Roubal, Katelynn Granger, James A Davis, Kelly J Gaffney, Erin Weeda, Hamza Hashmi> ;Leukemia & Lymphoma. 2023 Sep 1
• Outcomes of Penta-Refractory Multiple Myeloma Patients Treated with or without BCMA-Directed Therapy.
  Shebli Atrash, Aytaj Mammadzadeh, Fulei Peng, Omar Alkharabsheh, Aimaz Afrough, Wei Cui, Zahra Mahmoudjafari, Al-Ola Abdallah, Hamza Hashmi> ;Cancers. 2023 May 24
• Effectiveness, Safety, and Cost Implications of Outpatient Autologous Hematopoietic Stem Cell Transplant for Multiple Myeloma.
  Jessica Marini, Andy Maldonado, Erin Weeda, Amarendra Neppalli, Hamza Hashmi, Kathy Edwards> ;Hematology/oncology and Stem Cell Therapy. 2023 May 23
• 13 citations
  Efficacy and Safety of CD34+ Stem Cell Boost for Delayed Hematopoietic Recovery After BCMA Directed CAR T-cell Therapy.
  James A Davis, Douglas W Sborov, William Wesson, Kelley Julian, Al-Ola Abdallah, Joseph P McGuirk, Nausheen Ahmed, Hamza Hashmi> ;Transplantation and Cellular Therapy. 2023 Sep 1
• Early versus standard management of chimeric antigen receptor therapy toxicities and management's impact on safety and efficacy.
  Kelly J Gaffney, James A Davis, Mary McGann, Kathy Edwards, Zaheer Ahmed, Colleen Butcher, Brian Greenwell, Brian T Hess, Hamza Hashmi> ;Journal of Oncology Pharmacy Practice. 2024 Jan 1
• 12 citations
  Umbilical cord blood or HLA-haploidentical transplantation: Real world outcomes vs randomized trial outcomes
  Paul O'Donnell, Claudio G. Brunstein, Ephraim J. Fuchs, Mei-Jie Zhang, Mariam Allbee Johnson, Joseph H. Antin, Eric S. Leifer, Hany Elmariah, Michael R. Grunwald, Hamz...> ;Transplantation and Cellular Therapy. 2021 Nov 10
• Efficacy and Safety of Daratumumab-based Regimens in Pretreated Light Chain (AL) Amyloidosis: A Systematic Review
  Hamid Ehsan, Abdul Rafae, Adeel Masood, Ahsan Wahab, Muhammad Khawar Sana, Iqraa Ansar, Arooj Umar, Amrat Ehsan, Hamza Hashmi, Karun Neupane> ;Clinical Lymphoma, Myeloma & Leukemia. 2021 Nov 1
• 21 citations
  Allogeneic Transplant and CAR-T Therapy After Autologous Transplant Failure in DLBCL: A Noncomparative Cohort Analysis.
  Mehdi Hamadani, Ajay K. Gopal, Marcelo C. Pasquini, Soyoung Kim, Xianmiao Qiu, Sairah Ahmed, Aleksandr Lazaryan, Vijaya Raj Bhatt, Andrew Daly, Premal Lulla, Stefan O....> ;Blood Advances. 2021 Oct 21
• Join now to see all